Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Dermatol ; 51(6): 869-872, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38214494

RESUMO

A 73-year-old man with diabetes mellitus was referred to our department for ultraviolet treatment for erythematous skin lesions with itching. On dipeptidyl peptidase-4 inhibitor (DPP-4i) sitagliptin (Januvia®) for diabetes mellitus, the erythematous skin lesions appeared and spread to the whole body. At the initial visit, erythema multiforme-like skin lesions with crusts were observed on the trunk and extremities, and the patient was suspected to have drug eruption. Histopathology demonstrated eosinophilic infiltration in the superficial dermis and inflammatory cell infiltration in the epidermis. Sitagliptin was discontinued, and erythematous lesions improved with oral prednisolone. Thereafter the patient was treated with phototherapy and  betamethasone sodium phosphate infusion for residual prurigo. However, blistering skin lesions appeared 5 months later. Histopathological findings were subepidermal blisters with eosinophilic abscess, and bullous pemphigoid was suspected. CLEIAs for autoantibodies to desmoglein 1 (Dsg1), Dsg3 and BP180 were negative. Direct immunofluorescence showed linear depositions of immunoglobulin G (IgG) and C3 at the epidermal basement membrane zone, and indirect immunofluorescence detected IgG anti-epidermal basement membrane zone antibodies, reacting with the dermal side of 1M NaCl-split normal human skin. IgG antibodies reacted with 200 kDa laminin γ1 (p200) by immunoblotting using dermal extracts. These results indicated that this patient was diagnosed with anti-laminin γ1 (p200) pemphigoid developed after DPP-4i administration. Although reports of DPP-4i-related bullous pemphigoid have accumulated, cases of anti-laminin γ1 (p200) pemphigoid developed after DPP-4i administration are rarely reported.


Assuntos
Autoanticorpos , Inibidores da Dipeptidil Peptidase IV , Laminina , Penfigoide Bolhoso , Fosfato de Sitagliptina , Humanos , Masculino , Idoso , Inibidores da Dipeptidil Peptidase IV/efeitos adversos , Penfigoide Bolhoso/induzido quimicamente , Penfigoide Bolhoso/imunologia , Penfigoide Bolhoso/diagnóstico , Penfigoide Bolhoso/patologia , Penfigoide Bolhoso/tratamento farmacológico , Laminina/imunologia , Autoanticorpos/imunologia , Autoanticorpos/sangue , Fosfato de Sitagliptina/efeitos adversos , Pele/patologia , Pele/efeitos dos fármacos , Pele/imunologia , Toxidermias/etiologia , Toxidermias/patologia , Toxidermias/diagnóstico , Toxidermias/imunologia , Prednisolona/uso terapêutico , Prednisolona/administração & dosagem , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/imunologia , Diabetes Mellitus Tipo 2/complicações
2.
J Immunol ; 200(4): 1471-1479, 2018 02 15.
Artigo em Inglês | MEDLINE | ID: mdl-29335257

RESUMO

Canonical Ag-dependent TCR signaling relies on activation of the src-family tyrosine kinase LCK. However, staphylococcal superantigens can trigger TCR signaling by activating an alternative pathway that is independent of LCK and utilizes a Gα11-containing G protein-coupled receptor (GPCR) leading to PLCß activation. The molecules linking the superantigen to GPCR signaling are unknown. Using the ligand-receptor capture technology LRC-TriCEPS, we identified LAMA2, the α2 subunit of the extracellular matrix protein laminin, as the coreceptor for staphylococcal superantigens. Complementary binding assays (ELISA, pull-downs, and surface plasmon resonance) provided direct evidence of the interaction between staphylococcal enterotoxin E and LAMA2. Through its G4 domain, LAMA2 mediated the LCK-independent T cell activation by these toxins. Such a coreceptor role of LAMA2 involved a GPCR of the calcium-sensing receptor type because the selective antagonist NPS 2143 inhibited superantigen-induced T cell activation in vitro and delayed the effects of toxic shock syndrome in vivo. Collectively, our data identify LAMA2 as a target of antagonists of staphylococcal superantigens to treat toxic shock syndrome.


Assuntos
Enterotoxinas/imunologia , Laminina/imunologia , Ativação Linfocitária/imunologia , Infecções Estafilocócicas/imunologia , Linfócitos T/imunologia , Animais , Humanos , Células Jurkat , Camundongos , Camundongos Endogâmicos C57BL , Choque Séptico/imunologia , Staphylococcus aureus/imunologia , Superantígenos/imunologia
3.
Scand J Immunol ; 44(5): 535-9, 1996 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8947607

RESUMO

Secretory antibodies against bacteria and viruses in human colostrum and milk are known to be important protective factors for the breast-fed infant. The authors have shown by enzyme immunoassay that colostrum contains IgA and IgM antibodies to a number of autoantigens: native DNA, actin, myosin, myoglobin, laminin, transferrin and thyroglobulin. These antibodies were polyspecific-those with anti-DNA reactivity immunopurified on a DNA-cellulose affinity column bound to a panel of self- and environmental antigens. The levels of natural autoantibodies in the immunoglobulin fraction of human colostrum were 3-10 times lower (when presented as antibody activity per microgram of immunoglobulin) than in the immunoglobulin fraction of serum. The biological significance of the presence of B cells with autoantibody specificity in the mammary gland and of natural autoantibodies in colostrum and milk is not clear. It has been suggested that self-reacting autoantibodies in serum play a major role in the selection of the pre-immune B-cell repertoire and in the maintenance of the immune homeostasis. The authors hypothesize that the natural autoantibodies in colostrum and milk may contribute to the selection process of physiological repertoire during the early postnatal period in breast-fed infants. This could explain the lower frequency of allergic, inflammatory and autoimmune diseases and lymphomas which is seen in their later life when compared with that observed in children who have been formula-fed after birth.


Assuntos
Autoanticorpos/imunologia , Colostro/imunologia , Imunidade Materno-Adquirida , Imunoglobulina A/imunologia , Imunoglobulina M/imunologia , Leite Humano/imunologia , Especificidade de Anticorpos , Autoanticorpos/isolamento & purificação , DNA/imunologia , Feminino , Humanos , Imunoglobulina A/isolamento & purificação , Imunoglobulina G/imunologia , Imunoglobulina G/isolamento & purificação , Imunoglobulina M/isolamento & purificação , Laminina/imunologia , Proteínas Musculares/imunologia , Gravidez , Tireoglobulina/imunologia , Transferrina/imunologia
4.
QJM ; 88(1): 23-8, 1995 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7534597

RESUMO

To investigate possible mechanisms of hydrocarbon or solvent-induced renal damage, we studied three groups of healthy men employed in a UK manufacturing plant. Group 1 (n = 111) were occupationally exposed to hydrocarbon-based paints, Group 2 (n = 100) were occupationally exposed to petroleum-based mineral oils, and Group 3 (n = 92) had low background occupational exposure to hydrocarbons. Occupational atmospheric exposure levels for toluene, xylene, butanol and oil mist around the time of this study were within UK permissible limits. Group 4 (controls) were males with no known occupational hydrocarbon or solvent exposure (n = 108). Circulating laminin antibodies and the auto-antibody implicated in Goodpasture's syndrome (anti-GBM) were measured, as were serum laminin, a basement membrane turnover marker, and soluble E-selectin, an endothelial activation marker. Group 1 had a significantly greater proportion of subjects with high levels of both anti-laminin antibodies and soluble E-selectin; Group 2 had significantly more subjects with raised anti-GBM antibodies, laminin and soluble E-selectin. Mean levels of soluble E-selectin were increased in Groups 1 and 2. In a small but significant proportion of these workers exposed to hydrocarbons/mixed solvents there are alterations both to basement membranes, resulting in auto-antibody production, and to overlying vascular endothelial cells.


Assuntos
Autoanticorpos/sangue , Moléculas de Adesão Celular/sangue , Hidrocarbonetos/efeitos adversos , Glomérulos Renais/efeitos dos fármacos , Laminina/sangue , Exposição Ocupacional/efeitos adversos , Solventes/efeitos adversos , Adulto , Anticorpos/sangue , Membrana Basal/efeitos dos fármacos , Biomarcadores/sangue , Adesão Celular , Selectina E , Humanos , Laminina/imunologia , Masculino , Pessoa de Meia-Idade , Petróleo/efeitos adversos , Análise de Regressão
5.
J Immunol ; 143(12): 4188-92, 1989 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-2592771

RESUMO

The increase of mast cells at sites of tissue inflammation suggests the production of local factors chemotactic for mast cells. In this report, we demonstrate that the murine mast cell line PT18 and primary mouse bone marrow-derived mast cells chemotax to the basement membrane glycoprotein laminin, and that the synthetic laminin A chain-derived peptide, PA22-2, represents a region of laminin that contains a major chemoattractant site. Mast cell chemotaxis to laminin is enhanced after activation of mast cells by the calcium ionophore, A23187, or PMA and by sensitization of the cells with IgE followed by exposure to antigen. Chemotaxis is not increased in the presence of IL-3 and is independent of mast cell degranulation, as histamine release did not occur when cells were activated with PMA. Mast cell chemotaxis to laminin and its enhancement by IgE-dependent mast cell activation provides a mechanism by which these cells may be attracted to sites of tissue injury. Such activity may be particularly relevant in the response of host tissues to inflammation accompanying parasitic infestations, allergic reactions, and wound healing.


Assuntos
Adjuvantes Imunológicos/farmacologia , Fatores Quimiotáticos/farmacologia , Imunoglobulina E/fisiologia , Laminina/farmacologia , Mastócitos/imunologia , Animais , Linhagem Celular , Quimiotaxia/efeitos dos fármacos , Colágeno/farmacologia , Fibronectinas/farmacologia , Soros Imunes/farmacologia , Imunossupressores/farmacologia , Laminina/imunologia , Mastócitos/efeitos dos fármacos , Camundongos , Peptídeos/farmacologia
6.
J Neuroimmunol ; 20(1): 83-91, 1988 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-3141475

RESUMO

The monoclonal antibody INO (inhibitor of neurite outgrowth) has been shown to bind to a complex of laminin and a heparan sulfate proteoglycan and to block the action of this complex in promoting neurite outgrowth. We now report that the same antibody binds to cytoplasmic constituents in rat adenohypophyseal gonadotropes, as well as to vasopressinergic neurons in the hypothalamus and their terminals in the neurohypophysis. INO immunoreactivity in fixed sections of pituitary does not colocalize with the immunoreactive laminin in blood vessels and glandular basement membranes, although when unfixed tissue is washed in buffer prior to fixation, the INO immunoreactivity appears in these laminin-rich structures. These observations suggest similarities between the INO hypophyseal antigen and the neurite-promoting proteoglycan complex characterized in conditioned media. Presence of this complex in specific neurosecretory cell types suggests that it is involved with specific secretory products with function yet to be determined.


Assuntos
Anticorpos Monoclonais/imunologia , Hipotálamo/imunologia , Neurônios/imunologia , Hipófise/imunologia , Vasopressinas/fisiologia , Animais , Hormônio Foliculoestimulante/imunologia , Hipotálamo/citologia , Imuno-Histoquímica , Laminina/imunologia , Hormônio Luteinizante/imunologia , Hipófise/citologia , Adeno-Hipófise/citologia , Adeno-Hipófise/imunologia , Neuro-Hipófise/citologia , Neuro-Hipófise/imunologia , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA